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Summary.-A series of 257 cases of carcinoma of the male breast in Denmark has
been examined with a view to establishing the factors which might influence the
prognosis. Observed and corrected 5-year survival rates of 36% and 46% respec-
tively correspond well with the results in other series. Expressed by corrected
survival rate, the prognosis appears to be somewhat more favourable during the
period 1958-71 than during the period 1943-57. This improvement of prognosis
can be related to a significantly better clinical stage of advancement during the
latter period. Comparison of the 5-year corrected survival rates in series of male
and female breast cancer shows that the prognosis in male breast cancer is not much
worse than the prognosis in females. It has been proved that the duration of disease,
the clinical stage and the histological degree of malignancy influence the prognosis
considerably. The therapeutic results in our series correspond well with the results
found in other series. We did not find any evidence to indicate that it would be
better to carry out radical mastectomy than to do simple mastectomy since radical
mastectomy has not given consistently better results. It is recommended that
treatment of this rather uncommon disease be centralized as far as possible.
THE PROGNOSIS of breast cancer is
presumed to be much poorer in males than
in females.
The purpose of this study is to investi-
gate which factors might influence the
prognosis in male breast cancer and to
test the above statement on the basis of
our own material and on a review of the
literature.
MATERIAL AND METHODS
The material consists of 257 cases of
carcinoma of the male breast collected from
all over Denmark, using the files ofthe Danish
Cancer Registry. It comprises all cases
recorded during the period from 1 January
1943 to 1 July 1972. The patients were
recorded from hospitals from all over the
country and the series is therefore assumed
to be unselected.
Histological preparations from 187 cases
of the present group were reviewed (Visfeldt
and Scheike, 1973). The oestradiol meta-
18
bolism was studied in 19 patients (Scheike,
Svenstrup and Frandsen, 1973a). The asso-
ciation between the Klinefelter syndrome
and breast cancer has been studied (Scheike,
Visfeldt and Petersen, 1973b). The associa-
tion between gynaecomastia and breast
cancer has also been investigated (Scheike
and Visfeldt, 1973) and finally, the clinical
aspects of the disease have been recorded and
evaluated (Scheike, 1973).
It was possible to obtain and review the
original hospital records for all 257 patients
of the present series. Six of these cases were
not histologically verified. Nevertheless, they
have been included because the clinical
diagnosis and the clinical course were
unmistakeable. Most patients received radia-
tion therapy at the Radium Centers in
Copenhagen, Arhus and Odense, whereas
surgical treatment was carried out in hos-
pitals all over the country. Since the analysis
was concluded on 1 July 1972, we can submit
5-year results for 215 patients (84%) and
10-year results for 165 patients (64°,).
Four patients could be followed up for onlyOLE SCHEIKE
a very short period after treatment, but in
all these cases death certificate data were
available which made it possible to classify
them as having recurrence within 5 years
and to have died from the primary disease.
Unless otherwise stated, survival rate means
the crude survival rate 5 years after com-
mencement of treatment. In the following,
" corrected survival rate " is defined as the
observed survival rate expressed as a percen-
tage of the expected survival rate for a male
population of the same age distribution as
our patients.
k In the tables with n x 2 cells (n > 2),
the chi-square test described by Edwards
(1958) was used.
On the basis of data obtained from the
case records and from the surviving patients,
a number of factors have been correlated
to the survival rate, in order to clarify which
factors exert the greatest influence on the
prognosis in male breast cancer.
RESULTS
Total survival.-The survival rates in
249 patients with a follow-up period of
one year or more are shown in Fig. 1.
The observed and corrected 5-year sur-
vival rates were 36% and 46% respec-
tively, and the observed and corrected
10-year survival rates, 17% and 29%
respectively. Fig. 2 shows corrected sur-
vival rates for the patients during the
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periods 1943-57 and 1958-71. It will
be seen that the corrected survival rate
is somewhat higher during the latter
period. This may be due to a significant
improvement in clinical stage of advance-
ment during the latter period (Scheike,
1973).
The 5-year survival rates observed.in a
number of series of male breast cancer, in
which corrected survival rates had been
calculated, are shown in Table I.
Age andprognosis.-In ordertoinvesti-
gate whether age exerts any influence on
the prognosis, the cases were di'fided into
two groups: patients under 65 years, and
patients of 65 years or more. Fig. 3
shows the survival rates in these two
groups.
The observed 5-year survival rate for
the younger patients was 44-5% and for
the elderly patients 29-5%. However, in
the younger group the corrected 5-year
survival rate was 47.5%, and in the
elderly group, 43.9%. The corrected
10-year survival rate was 28-8% in the
younger group and 29-3% in the elderly.
Hence, there is no significant difference
between the two groups, neither in
respect of the 5-year nor of the 10-year
corrected survival rate. In Table II the
age is related to the histological grade of
malignancy. It will be seen that the
5 6
YEARS
FIG. 1. Survival among 249 cases of carcinoma of the male breast from all Denmark, 1943-72.
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TABLE I.-The Prognosis of Male Breast Cancer in Different Materials
Author
Moss (1964)
MacKay and Sellers (1965)
Norris and Taylor (1969)
Mausner et al. (1969)
Present material
No. of cases
followed 5 years
248
91
111
72
215
5 year survival rate
_
I
Observed Corrected
(%) (%)
41
36
41
47
36
43
44
52
60
46
incidence of the three grades of malig-
nancy is rather uniform in the age groups.
It must be concluded, therefore, that our
series presented no correlation between
age and histological grade of malignancy.
Similar conditions were found in female
breast cancer (Bloom, 1950). Peltokallio
and Kalima (1969) found, in their series
of male breast cancer, that the prognosis
is less favourable in younger than in older
patients, assessed on the basis ofcorrected
survival rate. As regards female breast
cancer, most authors are of the opinion
that age and prognosis are not related
(Bloom, 1950).
Duration of symptoms and prognosis.-
In males with breast cancer, the diagnosis
is established much later than in women.
In the present series, the mean duration
of symptoms was 20-8 months; in 16%
of the cases it was 3 years or more (Table
100
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III). Table III shows the influence of
the duration of symptoms on the progno-
sis. In patients with a duration of
symptoms of one year or more, the prog-
nosis corresponds to, or is slightly more
favourable than, that seen in patients
with the shortest duration of symptoms.
Williams (1942) and Triska (1967) found
similar conditions in their series of male
breast cancer. It might well be that
patients with symptoms of long duration
had slowly growing tumours, whereas
patients with symptoms of short duration
had rapidly growing tumours. Another
explanation could be that, in patients
with symptoms of long duration, the
tumour had been benign for a long period,
e.g., gynaecomastia. Bloom (1950),
Smithers et al. (1952), and Haagensen
(1972) found that in series of female
breast cancers, the prognosis was no
YEARS
FIG. 2.-Corrected survival among patients from the period 1943-57 and the period 1958-71.
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FIG. 3. Corrected survival among patients <65 years (111 cases) and > 65 years (138 cases).
TABLE II. Age in Relation to Grade
Age Grade
I
<55 II
III
55-70 II
III
> 70 II
III
Cases
No. %
8 26
16 52
7 23
15 25
36 59
10 16
21 :36
30 52
7 12
poorer in patients with symptoms of long
duration than in patients with symptoms
of short duration.
Hence, the results indicate that the
duration of symptoms alone is an inac-
curate parameter for the evaluation of the
prognosis in the individual patients, both
in male and female breast cancer.
Clinical stage of advancement and
prognosis. On the basis of the data
obtained from the case records, it was
possible to divide 253 cases into stages
according to the original version of the
TNM classification (U.I.C.C. publication,
1968).
The data correlating the clinical stage
ofadvancement and survival are presented
in Table IV. The advanced clinical stage
of disease carries a significantly less
favourable prognosis (P < 0 001 for 5-
and 10-year survival).
We have been unable to trace in the
literature any statistical review of the
dependence ofsurvival on the clinical stage
in male breast carcinoma. Among 248
patients and 72 patients with male breast
cancer, Moss (1964) and Mausner et al.
(1969) found 5-year survival rates of 59%
and 650% respectively, when the cancerwas
localized to the breast; survival rates of
3900 and 4300 respectively, inpatientswith
palpableregionallymphnodes; and,finally,
in patients with distant metastases, the
survival rates were 16% and 000 respec-
tively.
Each individual clinical symptom relat-
ing to the clinical stage is of great impor-
tance forthe prognosis. Table Vshowsthe
size of tumour related to the prognosis.
The 5-year survival rate decreases signifi-
TABLE III. Duration ofSymptoms and
Survival
Duration of symptoms
Less than 3 months
3-5 months
6-11 months
12-23 months
24-35 months
36 months or more
Total
Cases
No. 0
63 31
13 6
35 17
36 17
27 13
32 16
206 100
5-year survival
No. 0
24 38
4 31
8 23
13 36
12 44
13 41
74 36
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TABLE IV. Clinical Stage of Advancement and Survival. Total Material
5-year 10-year
No. of crude No. of crude
patients survival ,oatients survival
TNMl
stage
I
II
III
IV
Total
No.
89
28
107
29
253
followed
5 years
72
26
91
25
214
rate followed
(0)
58
38
29
4
36
10 years
53
21
66
24
164
rate
(%o)
38
10
9
0
17
cantly with increasing size of tumour
(P < 0 001). A similar correlation
between size of tumour and prognosis
was found by Norris and Taylor (1969).
Table VI presents the tumour size related
to the appearance of palpable regional
axillary lymph nodes, the frequency of
TABLE V. Tumour Size and 5-Year
Survival
Tumour size
<2 cm
>2-3 cm
> 3-4 cm
>4 cm
Total
No. of cases
followed 5 years
49
59
44
51
203
5-year survival
No. 0
27 55
23 39
16 36
8 16
74 36
which increases significantly with the size
of the tumour (P < 0.05). Norris and
Taylor (1969) found a similar relationship
between the size of tumour and frequency
of palpable regional axillary lymph nodes.
Thus, one of the reasons for the poorer
prognosis with increasing size of tumour
might be that the frequency of regional
lymph node metastases increases with the
increasing size of tumour.
Table VII presents the influence of
three other clinical symptoms on the
prognosis in our series. It will be seen
that whereas patients who on referral had
no palpable axillary lymph nodes, no
ulceration of the tumour and no fixation
of the tumour to underlying tissue have a
5-year survival rate of approximately
500o, the survival rate decreases signifi-
cantly to about 20% if the above clinical
symptoms are present.
TABLE VI.-Tumour Size in Relation to
Palpable Regional Axillary Nodes
No. of Palpable regional
cases axillary nodes
followed , *
Tumour size 5 years No. 00
<2 cm 49 14 29
>2-3 cm 59 22 37
>3-4 cm 44 20 45
>4 cm 51 33 65
Total 203 89 44
Histological grade of malignancy and
prognosis. It was possible to grade 150
cases in this series (Visfeldt and Scheike,
1973). Grading was carried out accord-
ing to the WHO recommendation (Scarff
and Torloni, 1968), and correlated with
prognosis. Fig. 4 presents the survival
curves for the three grades. There was a
significant decrease in the survival rate at
TABLE VII. 5-Year Results Grouped According to Different Clinical Symptoms
Clinical symptoms
Axillary nodes
Ulceration of tumour
Fixation to underlyilng
tissues
No noc(es, no ulceration,
no fixationi to
underlying tissues
No. of cases 5-year survival
followed
5 years No. %
93 21 23
58 13 22
50 13 26
85 43
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FiIG. 4. Survival of patients in relation to histological gracle of malignancy.
5 years and 10 years from Grades I to II
(P < 0 05 and P < 0 01, respectively) and
at 5 years from Grade II to Grade III
(P < 0.01) (Fisher's exact probability
test). A similar correlation between histo-
logical grade and prognosis in male breast
cancer was found by Greening and Aich-
roth (1965) and Liechty, Davis and Gley-
steen (1967), but these series were rather
small, 28 cases and 40 cases respectively.
Bloom and Richardson (1957) described
the same correlation between histological
grade and prognosis in 1409 patients with
female breast cancer.
Treatment and proynosis
(a). Curative treatment.-On the basis
of case record data it was possible to
classify 253 of the cases according to the
Columbia clinical classification (Haagen-
sen, 1972) into operable and inoperable
cases; 197 cases (78%) were operable, and
56 cases (22%) were inoperable.
The initial treatment of the operable
patients consisted in most cases of surgery
with or without post-operative radio-
therapy.
Surgical treatment was carried out in
hospitals all over the country and was not
uniform. It was: local excision (15 cases),
simple mastectomy (90 cases), modified
simple mastectomy (10 cases), radical
mastectomy (49 cases), modified radical
mastectomy (18 cases). As will be seen,
simple mastectomy was preferred, being
carried out almost twice as often as
radical mastectomy.
In 77% of the cases (141 cases), the
surgical treatment was combined with
radiotherapy; in the majority of cases in
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YEARS
FiG. 5.-Survival of operable patients (197 cases).
the form of conventional x-ray treatment
(150-400 kV). In only 6 cases was radio-
therapy the only primary treatment. Not
until 1969 was high voltage treatment
applied in the radiotherapy of these
patients. In most cases radiotherapy
was given in the Radium Centers in
Copenhagen, Arhus and Odense, although
many patients were treated in x-ray
departments in other hospitals. Conse-
quently, the technique varied greatly; in
only 67 of the total 141 cases was post-
operative radiotherapy given to the
regional lymph nodes, applying the Mc-
Whirter technique. In the remaining
cases fields and doses varied. The indica-
tions for supplementing surgical treatment
with radiotherapy were not clear; in most
hospitals radiotherapy wasgivenroutinely,
whether axillary lymph node metastases
were present or not. Radiotherapy was
most often given post-operatively (125
cases), in 8 cases pre-operatively and in 8
cases both before and after operation.
Fig. 5 shows the survival rates in the
operable patients, independent of type of
treatment. The observed and the cor-
rected 5-year survival rates were 43%
and 55% respectively; and the observed
and corrected 10-year survival rates were
22% and 37% respectively.
Table VIII shows the results of the
most frequently used methods of treat-
ment in the present material. When
comparing the results, certain reserva-
tions must be made. The age distribu-
tion of the patients varied somewhat in
some of the treatment groups and there
was a tendency to reserve the more
radical types oftreatment for the younger
patients. The median age for Stage I
patients (TNM classification), in whom
radical mastectomy was carried out with
or without radiotherapy, was 56-5 years,
whereas the median age for Stage I
patients in whom simple mastectomy was
carried out with or without radiotherapy,
was 685 years. Finally, the number of
patients within the groups compared is
not very great.
These factors weaken some of the con-
clusions concerning the influence of treat-
ment.
No statistically significant difference
in the treatment results was found
(Fisher's exact probability test).
As regards the Stage I cases they show,
with almost all types of treatment, a
considerably lower frequency of local/
regional recurrence than of distant meta-
stases. This might indicate that many
of the patients in whom an apparently
-J
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TABLE VIII.-Results of the Different iliodes of Treatment Used Most Frequently
in Operable Patients
5-yeai resiults
Simple mastectomy
with or without
radiotherapy
Simple mastectomy
+ post-operative
radiotherapy
Simple mastectomy
+ McWhirter
Simple mastectomy
alone
Radical mastectomy
with or without,
radiotherapy
Radical mastectomy
4- post-operative
radiotherapy
Radical mastectomy
alone
Survival
No. of rate
cases ( /o
All cases 64 50
Stage I cases 34 62
All cases
Stage I cases
All cases
Stage I cases
All cases
Stage T cases
44
26
28
19
18
8
5(
58
57
58
50
63
Recur-
rence-
free
survival
rate
(0oo)
Local/
Disease* Diseaset regional
+ - lrecurrence
(G%) (Go) (G%)
Distant
meta-
stases
(0oo)
36 44 56 31 28
53 32 68 1 8 24
36
54
39
53
33
50
All cases 48 48 31
Stage I cases 18 78 67
All cases
St,age I cases
All cases
Stage I cases
26
11
1 1
6
50
82
67
35
73
27
50
45
35
46
32
39
25
65
54
68
61
75
32
19
32
16
33
13
34
27
32
21
11
13
58 42 34 48
28 72 1 1 28
58
18
73
50
42
82
27
50
30
0
36
33
50
18
55
50
* Patients alive or dead writh dlisease at 5 years.
t Patients (lisease-free at 5 years or at time of (leath.
curative method oftreatment was applied,
might already have had disseminated
disease at the time of treatment.
A 5-year survival rate of 500/ in
patients treated with simple mastectomy
with or without radiotherapy, is com-
parable with the 53%o found in the series
published by Liechty et al. (1967).
On further comparison of the Stage I
patients, it will be seen that the more
radical interventions did not significantly
increase the survival rate or reduce the
incidence of local/regional recurrences or
distant metastases. In 143 patients men-
tioned in the literature as having received
the above treatment and been followed
up for 5 years, the survival rate was 4900
(Chrichlow, 1972).
(b). Palliative treatment. In many
cases radiotherapy was seen to exert a
growth-inhibiting effect on the tumour
and an analgetic effect on bone metastases,
but thesystemic treatment intheadvanced
stages was hormonal. Table IX shows
the results of the hormone treatment,
applied either primarily or secondarily.
In one third ofthe cases oestrogen therapy
in the form ofstilboestrol had a reasonable
palliative effect (> 6 months). The best
results were obtained when stilboestrol
was used as the primary method of treat-
ment. The longest period of remission
was 4 years. The dosage was most
frequLently 1 mg three times daily,
although great variations were seen.
Corticoids were usually applied as
secondary treatment and did not present
anylong-term palliativeeffect. Hypophy-
sectomy was used in one case without any
effect. Orchiectomy was not applied in
the present series. Manv authors main-
tain that orchiectomy is the treatment of
choice when the first symptoms of dis-
semination appear. For example, Treves
(1959) reported objective improvement
lasting for an average of 29-6 months in
28 out of 42 orchiectomized patients.
Chemotherapy was used either as
endoxan or methotrexate in 9 cases, in all
of them as secondary treatment. In
only 2 cases did the palliative effect last
for >6 months.
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TABLE IX. Results of Hormonal Treatment as a Primary or Secondary Measure
in Palliative Treatment
Treatment
Stilboestrol 63
Primary 13
Secondary 50
Corticosteroids 24
Primary 1
Secondlary 23
Anabolic steroils 5
Secondary 5
CONCLUSIONS
On the basis of the results obtained in
the present series the following conclusions
can be drawn:
(a) Total 5-year survival rate is 36%
(observed) and 46% (corrected). These
results correspond well with those found
by other authors (Table I).
(b) Prognosis seems to have improved
with time (Fig. 2).
(c) Age did not exert any influence on
the prognosis when this was expressed as
corrected survival rate (Fig. 3).
(d) It was not possible to compare the
present series with a similar unselected
series of female breast cancer in Denmark
registered during the same 30-year period
and similarly composed as to places and
methods of treatment.
Most authors maintain that males with
breast cancer have a much less favourable
prognosis than women. However, many
authors applied the observed survival
rate in this comparison. When com-
paring the prognosis in male and female
breast cancer, it is essential to consider
two factors: (1) the mortality from other
causes is higher in males than in females of
the same age; (ii) the average age in the
male patients is higher than that seen in
the females. Therefore, only the relative,
or corrected, survival rates can be com-
pared. Table I shows that the 5-year
corrected survival rate is as high as 60%
in unselected series of male breast cancer.
Moss (1964), MacKay and Sellers (1965),
and Mausner et al. (1969) compared
Palliationi
>6 months <6 months
>, 6 months < 6 months
6
14
4
7
36
19
corrected survival rates for unselected
series of female breast cancer registered
during the same period and from the same
treatment centres as the patients with male
breast cancer. The 5-year corrected sur-
vival rates in the female patients were
5600, 500 °and 630 °respectively. Because
of the rather limited numbers of cases in
the series of male breast cancer, the range
of sampling variability is greater than in
the series offemale breast cancer. Hence,
Moss (1964) considered the 5-year cor-
rected survival rates in female patients
to be only slightly better than in male
patients, and Mausner et al. (1969) con-
sidered the corrected 5-year survival rates
to be similar in female and male patients.
In the series of MacKay and Sellers
(1965), the survival rates by extent of
disease in males did not differ significantly
from those in women.
Hence, it must be concluded that, on
the basis of the most recent comparisons
of corrected 5-year survival rates in
females and males with this disease, the
prognosis in males is not much worse than
the prognosis in females.
(e) By itself, the duration ofsymptoms
is an inaccurate parameter for prognosis
(Table III). Prognosis can be poor in a
patient with a rapidly growing tumour
and symptoms of short duration, and good
in a patient with a slowly growing
tumour and symptoms of long duration.
However, this does not indicate that the
duration of symptoms is insignificant in
the prognosis in male breast cancer. It
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has previously been shown in this series
that the longer the patients have had a
tumour, the more advanced is the clinical
stage (Scheike, 1973), and the influence of
the clinical stage on the prognosis is
shown in Table IV. One of the reasons
for the possibly poorer prognosis in males
with breast cancer might be that the
duration of symptoms is considerably
longer than in women.
(f) The clinical TNM classification is
significantly related to the prognosis in
all four stages (Table IV).
(g) There is a significant correlation
between the histological grade of malig-
nancy and prognosis (Fig. 4). A compari-
son between the present series and series
of female breast cancer showed that there
were relatively fewer cases in the poorly
differentiated Group III in the present
series (Visfeldt and Scheike, 1973). A
possibly poorer prognosis in males with
breast cancer cannot, on the basis of the
present series, be ascribed to a higher
histological grade of malignancy, but
must rather be caused by a longer duration
of disease, and the anatomy of the male
breast with the sparse mammary tissue.
(h) Because of the selective processes
which in some cases determine how the
patients will be managed and because the
number of patients within the groups of
treatment compared is not very great,
some of the comments on the influence
of treatment must be taken with certain
reservations. Radical mastectomy does
not give consistently better results than
simple mastectomy (Table VIII). Hence,
simple mastectomy is perhaps to be pre-
ferred, since it has fewer post-operative
complications and is less strenuous, which
is an important factor considering that the
patients are on an average 65 years old,
400o being 70 years or older. Most
authors recommend radical mastectomy as
the optimum treatment in male breast
cancer (Somerville, 1952; Holleb, Freeman
and Farrow, 1968). However, some
authors maintain that simple mastectomy
is the treatment of choice (Greening and
Aichroth, 1965; Liechty et al., 1967). In
the series presented by these two groups of
authors, simple mastectomy with or with-
out radiotherapy gave just as good results
as radical mastectomy with or without
radiotherapy.
(i) Supplementary radiotherapy did
not improve the results of treatment
(Table VIII).
(j) The treatment of male breast cancer
should be centralized as much as possible,
since the disease is so uncommon (about
10-15 new cases in Denmark annually),
and since treatment often has to be
decided individually.
My thanks are due to Mr J. Nyboe,
Cand.act., statistician at Rigshospitalet,
Copenhagen, for his critical review of the
statistical calculations.
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